Search Results

Displaying: 25 / 100 / 200 results

Ordered by: Date (newest first) / Date (oldest first)

AstraZeneca stocks respiratory and cancer pipelines

31 July 2014 Business

A $2bn deal with Almirall and a raft of acquisitions and partnership deals bulk up two focus areas for the company

Bruker winds down underperforming instrument lines

30 July 2014 Business

Stand-alone gas chromatographs and certain mass spectrometry products to be sold off

Reckitt Benckiser to spin out US pharma arm

28 July 2014 Business

Declining heroin addiction treatment sales prompt divestment as company focuses on over-the-counter and consumer products

Takeover battle pushes Allergan to cut R&D jobs

28 July 2014 Business

Besieged by serially acquisitive Valeant, the Botox maker will lay off 1500 staff to propel earnings growth

Pharma firms rush to escape US tax shackles

25 July 2014 Business

AbbVie–Shire and Mylan–Abbott mergers both allow US firms to escape to lower-tax European countries

Tata Chemicals to mothball Kenya plant

24 July 2014 Business

Closure blamed on high energy prices and will mean 200 jobs being cut

Investigators find cause of West Virginia chemical spill

24 July 2014 Business

Holes in uninspected storage tanks led to leak that contaminated water supplies

Albemarle buys into lithium with Rockwood merger

23 July 2014 Business

$6.2 billion deal capitalises on battery market growth

Co-operation keeps contracts coming

11 July 2014 Business

Clubbing together gives contract research organisations more power to win new business in an evolving market

China struggles to speed up drug reviews

9 July 2014 Business

Regulator considers outsourcing reviews, and creates a fast-track scheme for priority generics

First of a new breed of anticancer antibodies approved in Japan

8 July 2014 Business

Ono claims Opdivo is the first anti-PD1 treatment in the world

ADM to buy food ingredients specialist Wild Flavors

8 July 2014 Business

€2.3bn deal gets ADM into rapidly-growing area of naturally-sourced flavourings

Ineos takes full control of Styrolution

3 July 2014 Business

€1.1bn deal sees BASF complete its planned exit from styrenics joint venture

EMA wrangles restrain trial data progress

3 July 2014 Business

Attempts to balance industry and research interests on transparency draw suggestions of improper collusion

Genentech to buy breast cancer specialist Seragon

2 July 2014 Business

$1.7bn deal for hormone receptor-destroying drug pipeline

PPG to buy Mexican paints firm Comex

1 July 2014 Business

$2.3bn deal expands US firm’s footprint in Central America

Bayer to close polycarbonate plant and cut 90 jobs

1 July 2014 Business

Firm has already shut Chinese plant, and will also sell off businesses in Australia and New Zealand

Affymax folds after drug withdrawal

30 June 2014 Business

Unexplained allergic reactions to anaemia drug prompt firm to dissolve

Inhaled insulin approved in US

30 June 2014 Business

European committee recommends approval for generic long-acting insulin

Lithium-ion battery makers look to stimulate electric car production

27 June 2014 Business

Tesla Motors opens up patents and manufacturers plan capacity increases

Biotech bounced back in 2013, says report

24 June 2014 Business

R&D investment increasing, but industry needs to use its cash more wisely

Shire fends off AbbVie takeover bid

23 June 2014 Business

Board says deal undervalues the company and its growth potential

Novo Nordisk to create 6000 jobs by 2022

16 June 2014 Business

Half of the new Danish employees will be in R&D roles

Medtronic to buy Covidien for $43bn

16 June 2014 Business

Tax inversion deal continues consolidation theme among medical device makers

Merck & Co bolsters hepatitis C pipeline with Idenix acquisition

12 June 2014 Business

Early-stage drugs complement Merck’s own developmental portfolio